Claude Bennett - Chief Operating Officer, Biocryst Pharmaceuticals Inc

As of March 18, 2008


Claude Bennett Net Worth

  • Net worth is estimated to be at least $1.6M
  • Owns at least 65,730 units of Biocryst Pharmaceuticals Inc stock
  • Sold an estimated value of $1.08M in the last 4 years at Biocryst Pharmaceuticals Inc

Claude Bennett Trading

  • Largest purchase of shares was 35,000 units , worth over $227.5K on May 5, 2006
  • Largest sale of shares was 26,243 units , worth over $397.13K on May 5, 2006
  • In total has made about 14 transactions over 4 years
  • Usually trades in May, with the busiest year in 2006
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Claude Bennett Mailing Address

  • Mailing address is C/o Biocryst Pharmaceuticals, Inc 2190 Pkwy Lake Drive Birmingham AL 35244 AL

Biocryst Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 5,000 units sold on September 17, 2021 by George Abercrombie worth over $75.3K
  • In the last 18 years, insiders at Biocryst Pharmaceuticals Inc sold an estimated value of $73.17M and bought an estimated value of $31.38M
  • The most active traders are Thomas Staab II, Senior Vice President and CFO,  Jon Stonehouse, President & CEO,  and William Sheridan, Chief Medical Officer
  • Insider trading is most common in May, with the busiest year in 2015

BIOCRYST PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1